| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 2037 |
| 1 | LEFLUNOMIDE | 2008 |
| 2 | RITUXIMAB | 2003 |
| 3 | ALENDRONATE SODIUM | 1998 |
| 4 | DICLOFENAC | 1966 |
| 5 | METHOTREXATE SODIUM | 1964 |
| 6 | SECUKINUMAB | 1958 |
| 7 | TOCILIZUMAB | 1954 |
| 8 | ADALIMUMAB | 1918 |
| 9 | METHOTREXATE | 1856 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 420 | 0.2199 |
| 1 | DICLOFENAC POTASSIUM TABLETS | 1289 | 0.1539 |
| 2 | NEOMYCIN OINTMENT | 347 | 0.1460 |
| 3 | CAFFEINE CITRATE | 305 | 0.1350 |
| 4 | DICLOFENAC POTASSIUM | 1289 | 0.1200 |
| 5 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 76 | 0.1187 |
| 6 | CORTISONE ACETATE | 1354 | 0.1103 |
| 7 | NICOTINAMIDE | 270 | 0.1081 |
| 8 | PSEUDOEPHEDRINE HCL | 1068 | 0.0975 |
| 9 | DESOXIMETASONE | 1760 | 0.0929 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2312 |
| 1 | Corticosteroid [EPC] | 2207 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2145 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 2038 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 2009 |
| 5 | Antirheumatic Agent [EPC] | 2008 |
| 6 | Interleukin-17A Antagonist [EPC] | 1958 |
| 7 | Vitamin C [EPC] | 1945 |
| 8 | Vitamin D [EPC] | 1867 |
| 9 | Vitamin B12 [EPC] | 1862 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 432 | 0.0222 |
| 1 | Endoglycosidase [EPC] | 201 | 0.0204 |
| 2 | Antirheumatic Agent [EPC] | 2008 | 0.0192 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 2009 | 0.0148 |
| 4 | Interleukin-5 Antagonist [EPC] | 723 | 0.0145 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 1171 | 0.0142 |
| 6 | beta3-Adrenergic Agonist [EPC] | 635 | 0.0137 |
| 7 | Interleukin-12 Antagonist [EPC] | 1380 | 0.0135 |
| 8 | Aminosalicylate [EPC] | 1730 | 0.0131 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 1671 | 0.0121 |